Clinic

Asensus Surgical, Inc. Reports Operating and Financial Results for the Third Quarter 2023

Retrieved on: 
Tuesday, November 14, 2023

We anticipate reaching important milestones in the upcoming quarters,” said Anthony Fernando, Asensus Surgical President and CEO.

Key Points: 
  • We anticipate reaching important milestones in the upcoming quarters,” said Anthony Fernando, Asensus Surgical President and CEO.
  • The LUNA System's development is in progress and is now entering the testing and evaluation phase before regulatory submissions.
  • Future milestones include freezing the system's design in early 2024, followed by verification and validation testing, and pilot manufacturing.
  • Revenue in the third quarter of 2023 included $0.5 million in lease revenue, $0.3 million in instruments and accessories, and $0.3 million in services.

Medit Unveils Enhanced Medit Link Software for Superior Scanner Performance

Retrieved on: 
Thursday, December 7, 2023

The highlight of these updates is Medit Link v3.2.0, which includes the release of Medit Scan for Clinics v1.11.0 and Medit Scan for Labs v1.6.0, each equipped with features that set new industry standards.

Key Points: 
  • The highlight of these updates is Medit Link v3.2.0, which includes the release of Medit Scan for Clinics v1.11.0 and Medit Scan for Labs v1.6.0, each equipped with features that set new industry standards.
  • The new Patient Menu in Medit Link v3.2.0 offers a streamlined method for managing cases by patient, enhancing organizational efficiency.
  • GB Ko, CEO of Medit, comments on the release: "These updates to Medit Link and Medit Scan software are more than just improvements; they are a testament to our commitment to innovate and lead in digital dentistry.
  • Michael Lee, CTO at Medit, emphasized the impact of these updates, stating, "With the latest enhancements in our Medit Link and Medit Scan software, we have taken a significant leap forward in optimizing the performance of intraoral scanners.

Practice Better Integrates That Clean Life, Further Empowering Health and Wellness Professionals

Retrieved on: 
Tuesday, December 5, 2023

TORONTO, Dec. 5, 2023 /PRNewswire/ -- Practice Better, the all-in-one practice management software platform for health and wellness professionals, today announced the integration of That Clean Life, the nutrition planning software acquired earlier this year. For the first time, Practice Better customers can seamlessly consolidate nutrition planning into their workflow from within their practice management platform to give them back time and improve client outcomes.

Key Points: 
  • TORONTO, Dec. 5, 2023 /PRNewswire/ -- Practice Better , the all-in-one practice management software platform for health and wellness professionals, today announced the integration of That Clean Life, the nutrition planning software acquired earlier this year.
  • Practice Better is one of the first practice management platforms to integrate nutrition planning functionality, making it easier for practitioners to provide more holistic care.
  • "Acquiring That Clean Life earlier this year was a significant opportunity for Practice Better.
  • The integration of That Clean Life with Practice Better will be a game changer, not only in my business but in the businesses of countless health practitioners using these platforms."

CONCENTRICLIFE PARTNERS WITH HARVEY MUDD COLLEGE TO BREAK BARRIERS TO ACCESS FOR CHILDREN'S PHYSICAL THERAPY

Retrieved on: 
Tuesday, December 5, 2023

NEW YORK, Dec. 5, 2023 /PRNewswire/ -- ConcentricLife, the promotional health and wellness platform now part of Accenture Song and nine-time Agency of the Year, has announced its project sponsorship for the Harvey Mudd College Clinic Program. The Clinic Program has a 60-year history of pioneering collaboration between education and industry to build leadership and impact society.

Key Points: 
  • The Clinic Program has a 60-year history of pioneering collaboration between education and industry to build leadership and impact society.
  • Together, ConcentricLife and Harvey Mudd College students will address the challenge of disrupted and limited access to desperately needed physical therapy due to a shortage of physical therapists in the healthcare workforce, a situation worsened by the global COVID-19 pandemic.
  • "We are thrilled to be working with ConcentricLife on this project, which has the potential to improve outcomes for children needing physical therapy," said Colleen Coxe, Assistant Vice President for Sponsored Research and Projects at Harvey Mudd College.
  • "The Health Fix is one of the initiatives that most embodies the real purpose of ConcentricLife,' says ConcentricLife co-founder and CEO, Ken Begasse.

Kerico Health Care Expands Non-Emergency Medical Transportation Services to Arkansas Following 300% Year-Over-Year Growth in Texas

Retrieved on: 
Saturday, December 2, 2023

HOUSTON, Dec. 2, 2023 /PRNewswire-PRWeb/ -- Kerico Health Care, a Houston-based provider of door-through-door Non-Emergency Medical Transportation (NEMT), is pleased to announce that its ride services have become available to seniors in Arkansas. The expansion comes on the heels of a staggering 300% year-over-year growth in Texas, where the startup has partnered directly with specialty clinics, hospitals, and primary care providers since 2018 to reduce no-show appointments by up to 40%.

Key Points: 
  • HOUSTON, Dec. 2, 2023 /PRNewswire-PRWeb/ -- Kerico Health Care , a Houston-based provider of door-through-door Non-Emergency Medical Transportation (NEMT), is pleased to announce that its ride services have become available to seniors in Arkansas.
  • The Arkansas launch builds upon Kerico Health Care's two-fold mission: to provide reliable medical appointment transportation to America's aging population and reduce the 50% no-show appointment rate across all medical appointments.
  • Entrepreneur Michael Morris was inspired to form Kerico Health Care while struggling to keep up with his mother's cancer treatment appointments.
  • Health care providers are realizing the impact the ride can have on a patient's preventative care appointment and patient experience."

WELL Health Reports Record Results for Q3-2023, Raises Guidance for Balance of 2023 and Provides Guidance of Over $900 Million in Revenue for 2024

Retrieved on: 
Tuesday, November 14, 2023

WELL is upgrading its guidance with the expectation that 2023 revenue will be between $755 million to $765 million reflecting improved organic growth expectations for the balance of the year.

Key Points: 
  • WELL is upgrading its guidance with the expectation that 2023 revenue will be between $755 million to $765 million reflecting improved organic growth expectations for the balance of the year.
  • We are ahead of our plan for reaching one billion in revenue and feel confident in introducing our guidance for 2024 of achieving over $900 million in annual revenue driven by organic growth.
  • Third Quarter 2023 Financial Highlights:
    WELL achieved record quarterly revenue of $204.5 million in Q3-2023, an increase of 40.2% as compared to revenue of $145.8 million generated in Q3-2022.
  • SaaS and Technology Services revenue was $15.9 million in Q3-2023, an increase of 10.3% as compared to $14.5 million in Q3-2022.

Female Filmmaker Duo Releases Thriller That Questions Culture's Beauty Obsession

Retrieved on: 
Monday, November 13, 2023

ATLANTA, Nov. 13, 2023 /PRNewswire-PRWeb/ -- A new thriller with a unique storyline and surprising plot twist goes behind the operating curtain of an underground cosmetic surgery clinic where a myriad of terrifying encounters await. "Clinic" takes viewers on a suspense-filled journey into a clinic that upends one woman's life forever. The latest movie released by the Atlanta-based female filmmaker duo Aleshia Cowser Jackson and Sharna L. Brown, "Clinic" follows a young single mother who decides to get a Brazilian Butt Lift against professional opinion. What was meant to be a three-hour procedure turns into a fight for her life and the gut-wrenching ordeal is portrayed on screen by Eyeam Cinema. "Clinic" is streaming now on Amazon Prime Video.

Key Points: 
  • The latest movie released by the Atlanta-based female filmmaker duo Aleshia Cowser Jackson and Sharna L. Brown, "Clinic" follows a young single mother who decides to get a Brazilian Butt Lift against professional opinion.
  • "Our films are intended to be both thought-provoking and entertaining, and this film raises some pretty complex questions."
  • – Eyeam Cinema CEO, Aleshia Cowser Jackson
    "We're proud of this film," says Aleshia Cowser Jackson, the founder and CEO of Eyeam Cinema.
  • Thus, our films are intended to be both thought-provoking and entertaining, and this film raises some pretty complex questions."

Select physicians from Medical Clinic of Houston now offering flexible membership medicine programs from Concierge Choice Physicians

Retrieved on: 
Friday, November 10, 2023

ROCKVILLE CENTRE, N.Y., Nov. 10, 2023 /PRNewswire/ -- Concierge Choice Physicians (CCP), the nation's leading full-service concierge medical service provider, announces that seven additional physicians from Medical Clinic of Houston, L.L.P. (MCH) are now offering CCP's Hybrid Choice™, an optional service that gives patients peace of mind with greater connectivity between doctor and patient. They join five other physicians from MCH, who offer the Hybrid Choice and the classic CCP full-model concierge program.

Key Points: 
  • Innovative healthcare models offer more time, convenience and a closer doctor-patient relationship
    ROCKVILLE CENTRE, N.Y., Nov. 10, 2023 /PRNewswire/ -- Concierge Choice Physicians (CCP) , the nation's leading full-service concierge medical service provider, announces that seven additional physicians from Medical Clinic of Houston, L.L.P.
  • (MCH) are now offering CCP's Hybrid Choice™, an optional service that gives patients peace of mind with greater connectivity between doctor and patient.
  • They join five other physicians from MCH, who offer the Hybrid Choice and the classic CCP full-model concierge program.
  • For more information, to join, or to inquire about availability, contact Concierge Choice Physicians at (877) 888-5590.

A new clinical study highlights efficiency in spine surgery of NextAR Spine, augmented reality surgical application

Retrieved on: 
Thursday, December 14, 2023

A new clinical study highlights efficiency in spine surgery of NextAR Spine, augmented reality surgical application

Key Points: 
  • A new clinical study highlights efficiency in spine surgery of NextAR Spine, augmented reality surgical application
    A new clinical study highlights efficiency in spine surgery of NextAR Spine, augmented reality surgical application
    CASTEL SAN PIETRO, 14 December 2023 - Medacta Group SA (“Medacta”, SIX:MOVE), a Swiss company specializing in the design, production, and distribution of innovative, personalized, and sustainable solutions for joint replacement, sports medicine, and spine surgeries, announces the publication of a new study in the European Spine Journal which demonstrates that NextAR Spine seamlessly integrates into the OR workflow, enabling the surgeon to enhance efficiency, accuracy, and versatility in spine surgery.
  • As stated in our recent study, NextAR, the new AR-assisted navigation system, greatly simplifies pedicle screw placement, ensuring effectiveness and accuracy.
  • The study “Evaluating a cutting‑edge augmented reality‑supported navigation system for spinal instrumentation” 1 led by Prof. Dr. med.
  • The NextAR surgical platform is part of Medacta's MySolutions Personalized Ecosystem , a network of advanced digital solutions designed to improve patient outcomes and healthcare efficiency.

Vaxcyte Doses First Participants in Phase 1/2 Clinical Study Evaluating VAX-31 for the Prevention of Invasive Pneumococcal Disease in Adults

Retrieved on: 
Thursday, November 9, 2023

SAN CARLOS, Calif., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases, today announced that the first participants were dosed in a Phase 1/2 clinical study for VAX-31, a 31-valent pneumococcal conjugate vaccine (PCV) candidate designed to prevent invasive pneumococcal disease (IPD), in adults. The study, which will evaluate the safety, tolerability and immunogenicity of VAX-31, is expected to enroll approximately 1,000 adults aged 50 and older. The Company expects to announce topline data from the Phase 1/2 study in the second half of 2024.

Key Points: 
  • -- VAX-31, a 31-Valent Pneumococcal Conjugate Vaccine (PCV) Candidate, is the Broadest-Spectrum PCV to Enter the Clinic --
    -- VAX-31 is Designed to Provide Coverage for Approximately 95% of Invasive Pneumococcal Disease Circulating in the U.S.
  • The study, which will evaluate the safety, tolerability and immunogenicity of VAX-31, is expected to enroll approximately 1,000 adults aged 50 and older.
  • The Company expects to announce topline data from the Phase 1/2 study in the second half of 2024.
  • We look forward to sharing the anticipated topline study results from the VAX-31 study in adults aged 50 and older in the second half of 2024.”